Home Newsfeeds Wolfe Research Downgrades Aptiv to Peer Perform

Wolfe Research Downgrades Aptiv to Peer Perform

Wolfe Research analyst Rod Lache downgrades Aptiv (NYSE:APTV) from Outperform to Peer Perform.

byBenzinga Newsdesk

February 3, 2023

1 minute read

Wolfe Research analyst Rod Lache downgrades Aptiv (NYSE:APTV) from Outperform to Peer Perform.

Jones Soda Co. Adds Sparkle To Q1 Revenue, Strong Growth In Cannabis Segment

By Nicolas Jose Rodriguez

May 4, 6:08 PM

Jones Soda Co. (OTC: JSDA), a craft soda company known for its unconventional flavors, announced its financial results late Thursday for the first quarter that ended March 31, 2023.

JSDA

Keybanc Maintains Underweight on WestRock, Lowers Price Target to $36

By Benzinga Newsdesk

July 1, 4:42 AM

Keybanc analyst Adam Josephson maintains WestRock (NYSE:WRK) with a Underweight and lowers the price target from $44 to $36.

WRK

Verastem Presents Avutometinib And Defactinib Combination Program Updates At The 5th Annual RAS-Targeted Drug Development Summit

By Benzinga Newsdesk

September 28, 2:16 PM

Preclinical and Clinical Presentations Include Update on FRAME Study Low-Grade Serous Ovarian Cancer Efficacy DataVerastem Oncology, (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for

VSTM

Nio Stock Is Trading Higher: What’s Going On?

By Adam Eckert

June 13, 8:32 AM

NIO Inc (NYSE: NIO) shares continue to trade higher Tuesday after the company said it would lower prices on its vehicles this week. Several analysts also adjusted price targets

NIO

Wolfe Research Downgrades Aptiv to Peer Perform

Related Posts

Jones Soda Co. Adds Sparkle To Q1 Revenue, Strong Growth In Cannabis Segment

Keybanc Maintains Underweight on WestRock, Lowers Price Target to $36

Verastem Presents Avutometinib And Defactinib Combination Program Updates At The 5th Annual RAS-Targeted Drug Development Summit

Nio Stock Is Trading Higher: What’s Going On?